Seattle, WA, United States of America

Linda Madisen

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1993-2019

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Linda Madisen

Introduction

Linda Madisen is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the area of G protein-coupled receptors (GPCRs). With a total of 7 patents to her name, her work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Among her latest patents are two notable inventions: the "G protein coupled receptor 85 and SREB3 knockout mice and uses thereof" and a "Method of identifying a compound for the treatment or prevention of obesity." The first patent provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, along with methods for their production. These innovations are useful in diagnosing and treating diseases associated with GPCR dysfunction. The second patent also focuses on GPCR polypeptides and polynucleotides, offering methods for identifying compounds that can act as agonists or antagonists, thereby aiding in the treatment of obesity.

Career Highlights

Linda has worked with several notable companies throughout her career, including Oncogen and Omeros Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical research and biotechnology.

Collaborations

Throughout her career, Linda has collaborated with esteemed colleagues such as Anthony F Purchio and George A Gaitanaris. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

Linda Madisen's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of new diagnostic and therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…